HockleyJM, DunlopR, DaviesRJ. Survey of distressing symptoms in dying patients and their families in hospital and the response to a symptom control team. Br Med J1988; 296: 1715–1717.
2.
AhmedzaiS.Palliation of respiratory symptoms. In: DoyleD, HanksGWC, MacDonaldN (eds). Oxford Textbook of Palliative Medicine. Oxford: Oxford University Press, 1993; pp. 349–377, 362–364.
3.
TwycrossR.Pain relief in advance of cancer. Edinburgh: Churchill Livingstone, 1994; p. 393.
4.
DavisCL. The therapeutics of dyspnea. In: Cancer Surveys, Volume 21: Palliative Medicine: Problem areas in pain and symptom management. London: Imperial Cancer Research Fund, 1994; pp. 85–98.
5.
FarncombeM, ChaterS, GillisA.The use of nebulized opioids for breathlessness: a chart review. Palliat Med1994; 8: 306–312.
6.
DavisCL, PennK, A'HernR, DanielsJ, SlevinM.Single-dose randomized controlled trial of nebulized morphine in patients with cancer-related breathlessness. Palliat Med1996; 10: 64–65.
7.
JohanssonIGM, GrundstromN, AnnerssonRRG. Modulation of the airways excitatory neuronal pathways via alpha-2 adrenoceptors and opioid receptors. Acta Physiol Scand1988; 134 (suppl. 575): 29.
8.
RogersDF, BarnesPJ. Opioid inhibition of neurally mediated mucus secretion in human bronchi. Lancet1989; 1: 930–931.
9.
ChrubasikJ, WustH, FriedrichG, GellerE.Absorption and bioavailability of nebulized mot. phine. Br J Anaesth1988; 61: 228–230.
10.
HughesS, CalverlyPMA. Heroin inhalation and asthma. Br Med J1988; 297: 1511–1512.
